BN OMEGA 3-6-9 CAPSULES

Indications

• Gastroesophageal reflux disease (GERD)
• Peptic ulcers
• Dyspepsia
• Acid-base balance disorders

Dosage

Children: Refer to specific acid formulations and guidelines for dosing. General dosing depends on the acid and its clinical use.

Adults: Refer to specific acid formulations and guidelines for dosing. General dosing depends on the acid and its clinical use.

Mechanism of action

Acids exert their effects primarily by dissociating into protons and anions in solution, thereby lowering the pH of the surrounding environment. This proton donation can influence various physiological processes, including enzyme activity, ion transport, and cellular signaling pathways. For example, hydrochloric acid in the stomach aids in digestion and the absorption of certain nutrients.

Pharmacodynamics

The pharmacodynamic effects of acids are largely dependent on their concentration and the specific type of acid involved. Weak acids may dissociate partially, leading to a less pronounced effect, while strong acids fully dissociate, leading to significant changes in pH and potential tissue irritation. Acids can also interact with various receptors and enzymes, influencing metabolic pathways and physiological responses.

Pharmacokinetics

The pharmacokinetics of acids vary widely depending on their chemical structure. Strong acids, such as hydrochloric acid, do not significantly enter systemic circulation due to their rapid dissociation in aqueous environments. Weak acids may be absorbed through the gastrointestinal tract, where their absorption is influenced by pH, solubility, and the presence of food. Metabolism and excretion pathways also vary, with some acids being metabolized to bicarbonate or other metabolites before excretion, primarily via the kidneys.

Adverse effects

• Gastrointestinal irritation
• Nausea
• Vomiting
• Abdominal pain
• Diarrhea
• Electrolyte imbalance

Precautions

• Use with caution in patients with renal impairment
• Monitor for signs of gastrointestinal bleeding
• Consider potential interactions with other medications that may affect gastrointestinal motility or pH levels

Pregnancy

The safety of various acids during pregnancy may vary; consult specific guidelines for each acid. Generally, use should be limited to essential cases.

Breast-feeding

Caution is advised when using acids during breastfeeding; consult specific guidelines for each acid.

Storage

Store in a cool, dry place away from direct sunlight. Keep tightly closed and out of reach of children.

Indications

• Cognitive development and function
• Support in visual acuity
• Management of inflammatory conditions
• Cardiovascular health
• Neuroprotection

Dosage

Children: Refer to specific guidelines or consult a healthcare provider for appropriate dosing.

Adults: Refer to specific guidelines or consult a healthcare provider for appropriate dosing.

Mechanism of action

DHA is incorporated into cell membranes, particularly in the brain and retina, where it influences membrane fluidity and function. It also serves as a precursor for the synthesis of specialized pro-resolving mediators (SPMs) that help resolve inflammation. Additionally, DHA can modulate gene expression and signal transduction pathways, affecting neuronal growth, survival, and synaptic plasticity.

Pharmacodynamics

DHA has been shown to support cognitive function, visual acuity, and cardiovascular health. Its anti-inflammatory effects are mediated through the production of resolvins and protectins, which are derived from DHA and play a role in resolving inflammation and promoting tissue repair. DHA's beneficial effects on neural function are attributed to its role in maintaining neuronal integrity and promoting neurogenesis.

Pharmacokinetics

DHA is absorbed from the gastrointestinal tract and is distributed widely in body tissues, with a high concentration in the brain and retina. Its half-life varies, but it is typically metabolized in the liver. DHA levels can be influenced by dietary intake and the body's metabolic demands, with higher concentrations observed in individuals with higher fish consumption.

Adverse effects

• Gastrointestinal discomfort
• Nausea
• Diarrhea
• Increased bleeding tendency
• Allergic reactions

Interactions

• Anticoagulants may enhance the risk of bleeding
• Antiplatelet drugs may increase bleeding risk
• Some antihypertensive medications may interact

Precautions

• Caution in patients with bleeding disorders
• Monitor patients on anticoagulant therapy closely
• Assess for fish allergies before use

Pregnancy

Docohexaenoic acid (DHA) is generally considered safe during pregnancy and is important for fetal brain development. Consultation with a healthcare provider is recommended.

Breast-feeding

DHA is excreted in breast milk and is beneficial for breastfeeding infants. It is important for neurodevelopment.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Formulations

• Softgel capsules
• Liquid fish oil
• Powder for reconstitution

Indications

• Hyperlipidemia
• Cardiovascular disease prevention
• Rheumatoid arthritis
• Inflammatory bowel disease
• Major depressive disorder

Dosage

Children: Refer to BNF for Children for specific dosing guidelines.

Adults: Refer to BNF for specific dosing guidelines, generally available in the form of supplements or prescription formulations.

Mechanism of action

Eicosapentaenoic acid works by influencing the production of eicosanoids, which are signaling molecules derived from fatty acids. It competes with arachidonic acid in the enzymatic pathways, leading to the production of less inflammatory eicosanoids. This shift in eicosanoid production is believed to contribute to reduced inflammation and improved cardiovascular outcomes.

Pharmacodynamics

The pharmacodynamic effects of EPA include the modulation of lipid levels, reduction of triglycerides, and anti-inflammatory effects. It has been shown to decrease platelet aggregation and may improve endothelial function, thus contributing to cardiovascular protection.

Pharmacokinetics

Eicosapentaenoic acid is readily absorbed from the gastrointestinal tract following oral administration. It undergoes metabolic processes in the liver and is incorporated into cell membranes, affecting cell signaling and inflammatory responses. The half-life of EPA is variable, influenced by dosage and individual metabolism, and it is primarily excreted in the urine and feces.

Adverse effects

• Nausea
• Diarrhea
• Abdominal pain
• Flatulence
• Rash

Precautions

• Use with caution in patients with known hypersensitivity to fish or shellfish.
• Monitor patients on anticoagulant therapy due to potential for increased bleeding risk.

Pregnancy

There are no adequate and well-controlled studies in pregnant women. Eicosapentaenoic acid should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Eicosapentaenoic acid is excreted in breast milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Formulations

• Capsules
• Liquid formulations

Indications

• Nutritional support
• Management of dyslipidemia
• Support for cardiovascular health
• Anti-inflammatory therapies

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations based on age and condition.

Adults: Dosage varies widely depending on the specific type of fatty acid and the condition being treated. Refer to specific guidelines for dietary or therapeutic doses.

Mechanism of action

Fatty acids exert their effects through several mechanisms, including serving as energy sources, components of cell membrane phospholipids, and precursors for signaling molecules such as eicosanoids. They can modulate gene expression and influence metabolic pathways by activating nuclear receptors, such as peroxisome proliferator-activated receptors (PPARs).

Pharmacodynamics

Fatty acids influence lipid metabolism, inflammation, and insulin sensitivity. They can alter membrane fluidity and receptor function, impacting cellular signaling. Saturated fatty acids may promote inflammatory processes, while unsaturated fatty acids, particularly omega-3 and omega-6 fatty acids, can exert anti-inflammatory effects and promote cardiovascular health.

Pharmacokinetics

Fatty acids are absorbed in the intestine via passive diffusion and are transported in the blood bound to albumin or as part of lipoproteins. They are metabolized in the liver, where they can undergo beta-oxidation to generate energy or be converted into ketone bodies. The half-life varies depending on the type of fatty acid and its incorporation into various tissues.

Pregnancy

Consult with a healthcare provider before use, as the effects of fatty acids during pregnancy can vary.

Breast-feeding

Consult with a healthcare provider before use, as some fatty acids may be excreted in breast milk.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Anxiety disorders
• Epilepsy
• Muscle spasms
• Sleep disorders
• Neuropathic pain

Dosage

Children: Refer to specific pediatric dosing guidelines based on clinical indications and formulations available.

Adults: Refer to specific product guidelines or clinical protocols as dosages may vary based on the formulation and intended use.

Mechanism of action

GABA exerts its effects by binding to GABA receptors (specifically GABA-A and GABA-B receptors) in the brain. The binding leads to the opening of ion channels that allow the influx of chloride ions into the neuron, resulting in hyperpolarization of the neuron and decreased likelihood of action potential firing. This mechanism is pivotal in reducing anxiety, seizures, and muscle spasms.

Pharmacodynamics

The primary pharmacodynamic effect of GABA is its ability to inhibit neurotransmission, leading to sedation, relaxation, and anticonvulsant effects. GABA is also involved in various physiological processes, including the regulation of muscle tone and the modulation of mood.

Pharmacokinetics

GABA has a limited ability to cross the blood-brain barrier when administered orally, which may affect its bioavailability and efficacy as a therapeutic agent. It is primarily metabolized in the brain and liver, with its effects being influenced by the overall balance of excitatory and inhibitory neurotransmitters in the central nervous system. The half-life of GABA varies based on the route of administration and individual patient factors.

Contra-indications

• Hypersensitivity to gamma-aminobutyric acid or any component of the formulation
• Severe respiratory depression
• Acute or severe liver disease
• Myasthenia gravis
• Pregnancy (unless under specific medical advice)

Adverse effects

• Drowsiness
• Dizziness
• Ataxia
• Nausea
• Vomiting
• Hypotension
• Respiratory depression
• Dependence potential
• Withdrawal symptoms upon discontinuation

Interactions

• CNS depressants (e.g., alcohol, benzodiazepines) may enhance sedative effects
• Antidepressants may have additive effects leading to increased sedation
• Medications that affect liver enzymes may alter gamma metabolism

Precautions

• Use with caution in patients with a history of substance abuse
• Monitor for signs of respiratory depression, especially in the elderly or those with pre-existing respiratory conditions
• Gradual dose reduction is recommended to minimize withdrawal symptoms

Pregnancy

Not recommended unless the potential benefit justifies the potential risk to the fetus. Consult healthcare provider.

Breast-feeding

Use with caution. Gamma may be excreted in breast milk. Monitor infant for sedation.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

• Oral tablets
• Oral solutions
• Injectable forms

Indications

• Essential fatty acid deficiency
• Support for cardiovascular health
• Management of inflammatory conditions
• Potential benefit in obesity management and insulin sensitivity

Dosage

Children: Refer to the BNF for Children for specific dosing information for pediatric populations.

Adults: Refer to the BNF for specific dosing guidelines as it varies based on formulation and condition being treated.

Mechanism of action

Linoleic acid influences gene expression related to insulin sensitivity and adipose tissue metabolism. It has been shown to modify the expression of resistin and peroxisome proliferator-activated receptor-gamma (PPARgamma) in white adipose tissue, especially under conditions of high-fat diet-induced insulin resistance. By potentially reducing hyperinsulinemia and hyperglycemia, linoleic acid helps improve insulin sensitivity and regulates metabolic pathways associated with fat metabolism.

Pharmacodynamics

Linoleic acid is involved in lipid metabolism and inflammatory responses. It is known to affect the release of inflammatory mediators and has been associated with improved lipid profiles and reduced body fat in certain populations. Its roles in cell signaling and membrane fluidity contribute to various physiological functions, including cardiovascular health and metabolic regulation.

Pharmacokinetics

Linoleic acid is absorbed in the gastrointestinal tract and transported via chylomicrons into the bloodstream. It is metabolized in the liver and can be incorporated into various lipid pools in the body. The half-life and elimination pathways are dependent on dietary intake and individual metabolism. It is stored in adipose tissue and can be mobilized as needed by the body.

Pregnancy

Safety in pregnancy has not been established. Consult a healthcare professional before use.

Breast-feeding

Safety during breastfeeding has not been established. Consult a healthcare professional before use.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Capsules
• Soft gels
• Liquid

Indications

• Cardiovascular disease prevention
• Hyperlipidemia
• Inflammatory conditions
• Cognitive decline
• General nutritional supplementation

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations based on age and condition.

Adults: Refer to specific clinical guidelines for dosing recommendations based on the condition being treated. Generally, dietary intake should include sources rich in linolenic acid, such as flaxseed oil or walnut oil.

Mechanism of action

Linolenic acid exerts its effects through its incorporation into cell membranes, influencing membrane fluidity and function. It serves as a precursor for the synthesis of eicosanoids, which are signaling molecules that mediate various physiological processes, including inflammation and immune response. Additionally, it activates the peroxisome proliferator-activated receptor (PPAR), which plays a role in lipid metabolism and inflammation regulation.

Pharmacodynamics

Linolenic acid contributes to the regulation of lipid metabolism and has been shown to lower triglyceride levels in the blood. It also has anti-inflammatory effects that may reduce the risk of chronic diseases such as atherosclerosis, rheumatoid arthritis, and other inflammatory conditions. The conversion of linolenic acid to eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in the body further enhances its beneficial effects on cardiovascular and neurological health.

Pharmacokinetics

Linolenic acid is absorbed in the gastrointestinal tract, and its bioavailability is influenced by dietary fat intake. Once absorbed, it is transported in the bloodstream bound to lipoproteins. It can be metabolized in the liver to longer-chain fatty acids, such as EPA and DHA. The half-life of linolenic acid in the body is variable and depends on dietary intake and metabolic demands. The elimination is primarily through metabolic conversion and incorporation into cellular structures.

Adverse effects

• Diarrhea
• Nausea
• Abdominal pain
• Bloating
• Allergic reactions

Precautions

• Use with caution in patients with a history of allergies to fish or shellfish.
• Monitor for gastrointestinal discomfort in patients taking high doses.

Pregnancy

Consult a healthcare provider before use, as safety during pregnancy is not fully established.

Breast-feeding

Consult a healthcare provider before use, as safety during breastfeeding is not fully established.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Capsules
• Liquid oil

Indications

• Dietary supplement for cardiovascular health
• Nutritional support in metabolic disorders
• Excipients in pharmaceutical formulations
• Potential adjunct in the management of inflammatory conditions

Dosage

Children: Refer to specific product guidelines or clinical protocols for dosing recommendations, as oleic acid is typically used in dietary or supplemental forms, and exact dosages can vary based on formulation.

Adults: Refer to specific product guidelines or clinical protocols for dosing recommendations, as oleic acid is typically used in dietary or supplemental forms, and exact dosages can vary based on formulation.

Mechanism of action

Oleic acid exerts its effects primarily through its role in cell membrane composition and function. It influences the fluidity and permeability of membranes, which can affect various cellular signaling pathways. Additionally, oleic acid has been shown to modulate gene expression related to lipid metabolism and inflammation, and it may activate specific nuclear receptors such as peroxisome proliferator-activated receptors (PPARs).

Pharmacodynamics

Oleic acid is recognized for its beneficial effects on lipid profiles, including lowering low-density lipoprotein (LDL) cholesterol levels while increasing high-density lipoprotein (HDL) cholesterol levels. It possesses anti-inflammatory properties, potentially reducing the risk of chronic diseases associated with inflammation, such as cardiovascular diseases. The anti-inflammatory effects are thought to be mediated by the modulation of cytokine production and the inhibition of pro-inflammatory pathways.

Pharmacokinetics

Oleic acid is absorbed in the gastrointestinal tract and is transported in the bloodstream primarily as part of triglycerides and phospholipids. Its metabolism occurs in the liver and other tissues, where it can be oxidized for energy or incorporated into various lipid molecules. The distribution of oleic acid is widespread, as it is a component of cell membranes throughout the body. Oleic acid has a relatively long half-life, and its effects can persist beyond its direct presence in circulation.

Pregnancy

Oleic acid is generally recognized as safe when used in food and cosmetics. However, its effects during pregnancy have not been extensively studied, and caution is advised.

Breast-feeding

Oleic acid is present in breast milk and is considered safe during breastfeeding. However, consult a healthcare provider for personalized advice.

Storage

Store in a cool, dry place away from direct sunlight. Ensure containers are tightly sealed to prevent oxidation.

Formulations

• Oleic acid liquid
• Oleic acid ointments
• Oleic acid creams

Indications

• Cardiovascular disease prevention
• Hypertriglyceridemia
• Rheumatoid arthritis
• Inflammatory bowel disease
• Cognitive decline and dementia
• Mood disorders

Dosage

Adults: Dosage varies based on the condition being treated. For general health, a common recommendation is 250-500 mg of combined EPA and DHA

Mechanism of action

Omega fatty acids exert their effects through various mechanisms, including the modulation of inflammatory pathways and the synthesis of specialized pro-resolving mediators. They are incorporated into cell membranes, affecting membrane fluidity and receptor function. Omega-3 fatty acids can also decrease the production of pro-inflammatory eicosanoids and increase anti-inflammatory mediators, promoting a balanced inflammatory response.

Pharmacodynamics

The pharmacodynamics of omega fatty acids involve their role in cellular signaling, gene expression, and lipid metabolism. Omega-3 fatty acids, particularly EPA and DHA, have been shown to influence the resolution of inflammation and enhance endothelial function. They also play a role in neuroprotection and cognitive function, with evidence suggesting that adequate omega-3 intake is associated with reduced risk of neurodegenerative diseases.

Pharmacokinetics

Omega fatty acids are absorbed in the intestine through the action of bile salts and pancreatic enzymes. Once absorbed, they are transported via chylomicrons into the lymphatic system and then into the bloodstream. They are distributed throughout the body, particularly in the brain and heart. The half-life of omega fatty acids can vary, with some studies suggesting an elimination half-life of several days to weeks, depending on the specific fatty acid and individual metabolism. They undergo beta-oxidation for energy production and can be converted into eicosanoids, which mediate various physiological functions.

Adverse effects

• Nausea
• Diarrhea
• Fishy aftertaste
• Allergic reactions
• Increased bleeding risk

Interactions

• Anticoagulants may increase the risk of bleeding when combined with omega-3 fatty acids
• Antihypertensive medications may have additive effects on blood pressure

Precautions

• Use cautiously in patients with bleeding disorders
• Monitor patients on anticoagulants for signs of increased bleeding
• Consider the source of omega-3 fatty acids, as some may contain contaminants

Pregnancy

Generally considered safe when used in recommended amounts, but high doses should be avoided due to potential bleeding risk.

Breast-feeding

Considered safe; omega-3 fatty acids can be beneficial for both mother and infant.

Storage

Store in a cool, dry place, away from light. Refrigeration may be required for some formulations to maintain stability.

Formulations

• Capsules
• Softgels
• Liquid oil
• Fortified foods

Indications

• Prevention of vitamin E deficiency
• Antioxidant therapy
• Support in conditions related to oxidative stress

Dosage

Children: Refer to BNF for Children for specific dosage guidelines.

Adults: Refer to BNF for specific dosage guidelines.

Mechanism of action

Tocopherol acts as a radical scavenger, primarily functioning as an antioxidant for lipid bilayers. It donates hydrogen atoms to free radicals, trapping them and preventing cellular damage. Its effectiveness is influenced by its location within the membrane and its interaction with cytosolic reductants like ascorbate. Tocopherol can trap multiple radicals, including alkyl and peroxy radicals.

Pharmacodynamics

The antioxidant properties of tocopherol lead to significant pharmacodynamic effects, including the inhibition of cell death through modulation of protein kinase C (PKC). Tocopherol also exhibits anti-inflammatory effects, which can be attributed to its influence on cytokines, prostaglandins, prostanoids, and thromboxanes. These interactions may contribute to its protective effects in various pathological conditions.

Pharmacokinetics

Tocopherol is absorbed in the intestines and its bioavailability can be influenced by dietary fat intake. It is transported in the plasma primarily bound to lipoproteins. Tocopherol is stored in adipose tissue and the liver, and its elimination occurs through bile and urine. The half-life of tocopherol can vary depending on the individual's nutritional status and other factors.

Pregnancy

Tocopherol is generally considered safe during pregnancy, but it is advisable to consult a healthcare provider before use.

Breast-feeding

Tocopherol is excreted in breast milk, and while it is considered safe, a healthcare provider should be consulted for specific recommendations.

Storage

Store in a cool, dry place away from direct sunlight.

Mechanism of action

/The objective of this work was/ to study the gene expression of the resistin and the effects of conjugated linoleic acid on its expression in white adipose tissue of obese rats fed with high fat diet during the formation of insulin resistance. Male Wistar rats were randomly separated in control group, high-fat group and high fat + conjugated linoleic acid (CLA) group (0.75 g, 1.50 g, 3.00 g per 100 g diet weight), using reverse transcription polymerase chain reaction (RT-PCR) technique to measure the expression level of resistin and peroxisome proliferator-activated receptor-gamma (PPARgamma) mRNA expression. The serum insulin and glucose levels of obese rats were (11.11 +/- 2.73) mIU/L, (5.09 +/- 0.66) mmol/L, and supplement of CLA might decrease hyperinsulinemia and hyperglycemia, in CLA group (0.75 g, 1.50 g, 3.00 g per 100 g diet weight) the serum insulin levels were (6.99 +/- 1.77) mIU/L, (7.36 +/- 1.48) mIU/L, (7.85 +/- 1.60) mIU/L, and glucose levels were (4.28 +/- 0.72) mmol/L, (4.18 +/- 0.55) mmol/L, (4.06 +/- 0.63) mmol/L. The expression of resistin in adipose tissue of obese rat fed with high fat diet was increased as compared with those fed with basic diet. CLA might increase the expression of resistin and PPARgamma in adipose tissue of obese rat. The expression of resistin mRNA of obese rat fed with high fat diet was higher than those fed with basic diet, and CLA might improve the insulin resistance in obese rats and possibly upregulate the expression of resistin through activing PPARgamma. /Conjugated linoleic acid/ Conjugated linoleic acid (CLA) is a mixture of positional (e.g. 7,9; 9,11; 10,12; 11,13) and geometric (cis or trans) isomers of octadecadienoic acid. This compound was first shown to prevent mammary carcinogenesis in murine models. Later investigations uncovered a number of additional health benefits, including decreasing atherosclerosis and inflammation while enhancing immune function. The mechanisms of action underlying these biological properties are not clearly understood. The aim of this review is to highlight recent advances in CLA research related to experimental inflammatory bowel disease. In addition, two possible mechanisms of action (i.e. endoplasmic and nuclear) were discussed in detail in the context of enteric inflammatory disorders. Conjugated linoleic acid was first implicated in down-regulating the generation of inducible eicosanoids (i.e. PGE(2) and LTB(4)) involved in early micro-inflammatory events (endoplasmic). More recently, CLA has been shown to modulate the expression of genes regulated by peroxisome proliferator-activated receptors (PPARs; nuclear). In pigs, prolonged dietary CLA treatment stimulated the expression of PPAR-gamma in the muscle. Thus, evidence supporting both mechanistic theories of CLA acting through eicosanoid synthesis and PPAR activity is available. The further understanding of the anti-inflammatory mechanisms of action of CLA may yield novel nutritional therapies for enteric inflammation. /Conjugated linoleic acid/ /Conjugated linoleic acid/ CLA may modulate eicosanoid activity as well as the activity... of tumor necrosis factor-alpha. /Conjugated linoleic acid/

Mechanism of action

Tocopherol acts as a radical scavenger. It mainly acts as an antioxidant for lipid bilayers. Tocopherol's functions depend on the H-atom donating ability, location, and movement within the membrane, as well as the efficiency in the radical recycling by some cytosolic reductants such as ascorbate. Tocopherol actions are related to the trap of radicals, and it has been shown that even in the absence of substituents in the ortho-positions, tocopherol can trap more than two radicals. The type of radicals available for tocopherol are alkyl and peroxy.

Pharmacodynamics

The antioxidant effects of tocopherol can be translated into different changes at the pharmacodynamic level. In vitro studies have shown that this antioxidant activity can produce modification in protein kinase C (PKC) which will later be translated into an inhibition of cell death. Some other derivate effects are the anti-inflammatory properties of tocopherol which can be related to the modulation of cytokines or prostaglandins, prostanoids and thromboxanes.